Logo image of DOMA

Doma Holdings Inc (DOMA) Stock Fundamental Analysis

NYSE:DOMA - New York Stock Exchange, Inc. - US25703A2033 - Common Stock - Currency: USD

6.28  +0.15 (+2.45%)

After market: 6.28 0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to DOMA. DOMA was compared to 64 industry peers in the Real Estate Management & Development industry. DOMA may be in some trouble as it scores bad on both profitability and health. DOMA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year DOMA has reported negative net income.
DOMA had a negative operating cash flow in the past year.
In the past 5 years DOMA always reported negative net income.
DOMA had a negative operating cash flow in each of the past 5 years.
DOMA Yearly Net Income VS EBIT VS OCF VS FCFDOMA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 -100M -200M -300M

1.2 Ratios

DOMA's Return On Assets of -40.89% is on the low side compared to the rest of the industry. DOMA is outperformed by 83.08% of its industry peers.
Industry RankSector Rank
ROA -40.89%
ROE N/A
ROIC N/A
ROA(3y)-49.62%
ROA(5y)-33.35%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DOMA Yearly ROA, ROE, ROICDOMA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 -20K -40K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for DOMA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DOMA Yearly Profit, Operating, Gross MarginsDOMA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 -2K -4K -6K -8K -10K

0

2. Health

2.1 Basic Checks

DOMA does not have a ROIC to compare to the WACC, probably because it is not profitable.
DOMA has more shares outstanding than it did 1 year ago.
The number of shares outstanding for DOMA has been reduced compared to 5 years ago.
The debt/assets ratio for DOMA is higher compared to a year ago.
DOMA Yearly Shares OutstandingDOMA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
DOMA Yearly Total Debt VS Total AssetsDOMA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC7.44%
DOMA Yearly LT Debt VS Equity VS FCFDOMA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M -200M 300M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
DOMA Yearly Current Assets VS Current LiabilitesDOMA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

DOMA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 65.24%, which is quite impressive.
DOMA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.15%.
Measured over the past years, DOMA shows a very strong growth in Revenue. The Revenue has been growing by 399.50% on average per year.
EPS 1Y (TTM)65.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.72%
Revenue 1Y (TTM)-17.15%
Revenue growth 3Y-8.79%
Revenue growth 5Y399.5%
Sales Q2Q%-12.61%

3.2 Future

The Earnings Per Share is expected to grow by 21.20% on average over the next years. This is a very strong growth
DOMA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.16% yearly.
EPS Next Y43.68%
EPS Next 2Y25.15%
EPS Next 3Y21.2%
EPS Next 5YN/A
Revenue Next Year-38.59%
Revenue Next 2Y-15.97%
Revenue Next 3Y7.16%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DOMA Yearly Revenue VS EstimatesDOMA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
DOMA Yearly EPS VS EstimatesDOMA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -10 -20 -30

1

4. Valuation

4.1 Price/Earnings Ratio

DOMA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year DOMA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DOMA Price Earnings VS Forward Price EarningsDOMA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DOMA Per share dataDOMA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

DOMA's earnings are expected to grow with 21.20% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.15%
EPS Next 3Y21.2%

0

5. Dividend

5.1 Amount

DOMA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

Doma Holdings Inc

NYSE:DOMA (9/26/2024, 8:04:00 PM)

After market: 6.28 0 (0%)

6.28

+0.15 (+2.45%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)08-13 2024-08-13/amc
Earnings (Next)11-05 2024-11-05/amc
Inst Owners0.1%
Inst Owner Change-98.09%
Ins Owners628.98%
Ins Owner Change0%
Market Cap89.11M
Analysts45.71
Price Target6.42 (2.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.79%
Min EPS beat(2)-0.1%
Max EPS beat(2)5.67%
EPS beat(4)1
Avg EPS beat(4)-16.21%
Min EPS beat(4)-54.63%
Max EPS beat(4)5.67%
EPS beat(8)1
Avg EPS beat(8)-61.11%
EPS beat(12)3
Avg EPS beat(12)-36.2%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)19.15%
Min Revenue beat(2)-9.32%
Max Revenue beat(2)47.62%
Revenue beat(4)2
Avg Revenue beat(4)7.41%
Min Revenue beat(4)-28.13%
Max Revenue beat(4)47.62%
Revenue beat(8)3
Avg Revenue beat(8)0.36%
Revenue beat(12)6
Avg Revenue beat(12)2.76%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.05%
EPS NY rev (1m)0%
EPS NY rev (3m)10.03%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)62.94%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.23%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.29
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-6.41
EYN/A
EPS(NY)-4.07
Fwd EYN/A
FCF(TTM)-3.76
FCFYN/A
OCF(TTM)-3.35
OCFYN/A
SpS21.46
BVpS-4.23
TBVpS-6.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -40.89%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-49.62%
ROA(5y)-33.35%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.43
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 48.65%
Cap/Sales 1.93%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC7.44%
ROIC/WACCN/A
Cap/Depr(3y)200.27%
Cap/Depr(5y)252.98%
Cap/Sales(3y)5.49%
Cap/Sales(5y)4.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.72%
EPS Next Y43.68%
EPS Next 2Y25.15%
EPS Next 3Y21.2%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.15%
Revenue growth 3Y-8.79%
Revenue growth 5Y399.5%
Sales Q2Q%-12.61%
Revenue Next Year-38.59%
Revenue Next 2Y-15.97%
Revenue Next 3Y7.16%
Revenue Next 5YN/A
EBIT growth 1Y65.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year73.45%
EBIT Next 3Y25.59%
EBIT Next 5YN/A
FCF growth 1Y70.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y65.97%
OCF growth 3YN/A
OCF growth 5YN/A